The Danish comorbidity in liver transplant recipients study (DACOLT): a non-interventional prospective observational cohort study.

ABSTRACT:

Background

Liver transplantation is the only curative treatment for patients with end-stage liver disease. Short-term survival has improved due to improved surgical techniques and greater efficacy of immunosuppressive drugs. However, long-term survival has not improved to the same extent as the short-term survival, and the 10-year survival after liver transplantation is 60%. In addition to liver- and transplant-related causes, comorbidities such as cardiovascular, pulmonary, renal, and metabolic diseases have emerged as leading causes of morbidity and mortality in liver transplant recipients. The objective of this study is to assess the burden of comorbidities and identify both liver- and transplant-related risk factors as well as traditional risk factors that contribute to the pat

SUBMITTER: Thomsen MT 

PROVIDER: S-EPMC8017840 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature